Last reviewed · How we verify
Amprol (AMPROLIUM)
Amprol (Amprolium) is a small molecule modality targeting the thiamine transporter 1. Its exact drug class is unknown, and its commercial status is unclear. Amprol is used to treat thiamine deficiency, but its FDA approval status and approved indications are not specified. Key safety considerations are not well-documented. Further research is needed to fully understand its pharmacological properties.
At a glance
| Generic name | AMPROLIUM |
|---|---|
| Target | Thiamine transporter 1 |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Amprol CI brief — competitive landscape report
- Amprol updates RSS · CI watch RSS